Rintasyöpä
Study links aggressive breast cancers in younger women to gaps in screening guidelines
Raportoinut AI AI:n luoma kuva Faktatarkistettu
An 11-year review of breast cancer diagnoses from outpatient imaging centers in western New York found that women aged 18 to 49 accounted for roughly one-fifth to one-quarter of all cases, with many tumors in those under 40 described as invasive and biologically aggressive. The findings, presented at the Radiological Society of North America meeting, underscore calls for earlier, risk-based assessment for younger women.
Amanda Peet, 54, shared her breast cancer journey in a New Yorker essay, diagnosed in August 2025 amid her parents' hospice care. The actress detailed routine scans turning serious, treatable news, and family losses. 💔
Raportoinut AI
Uppsalalainen Kim Höglund kertoo matkastaan seksuaalisuutensa uudelleenlöytämiseen rintasyöpähoitojen jälkeen. Diagnoosi tuli marraskuussa 2022, kun hän oli 37-vuotias ja oli äskettäin tullut äidiksi. Hän toivoo terveydenhuollon informoineen paremmin intimiteetin ja seksin muutoksista.
Scientists from the Francis Crick Institute and Vividion Therapeutics have developed chemical compounds that prevent the RAS gene from signaling tumor growth via the PI3K pathway. The treatment stopped tumor growth in mice models of lung and breast cancer without causing side effects like hyperglycemia. It is now entering human clinical trials.